Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-01 11:45:13 - browse：84163

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

WSS

Infant mortality in U.S. rose last year for first time in decades: CDC

DeepMind touts AlphaFold's new skills as protein folding AI models face off

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

FDA approves RSV monoclonal antibody for infants, toddlers

How to convince healthy people to buy insurance

knowledge

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Medical leaders decry Supreme Court decision on affirmative action

How dance can help nurses traumatized by Covid

Affirmative action in medical school literally saved lives

Custom gene therapy hints at new path for rare disease treatments

At least 13 dead in Texas as scorching temps continue

Medicare must police algorithms in Medicare Advantage, Dems say

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Virtual Event: The State of Biosimilars: What to Watch

Peter Hotez and the public health issue of online harassment

How dance can help nurses traumatized by Covid

knowledge

The health care issue Democrats can’t solve: hospital reform

How to convince healthy people to buy insurance

Inari Medical to buy amputation prevention company LimFlow

WHO calls for emergency meeting on new China virus, as cases spread

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Key Senate panel to consider PBM, drug pricing reform package

leisure time

explore

entertainment

leisure time